SDZ-GLC-756 is a mixed-action dopaminergic drug that has been proposed for use in the treatment of eye diseases associated with high intraocular pressure. It is referred to as GLC756 in modern sources.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.